XML 48 R28.htm IDEA: XBRL DOCUMENT
v3.24.0.1

REVENUE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
REVENUE |
Schedule of Company's Disaggregation of Revenues | The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year Ended December 31,
(U.S. dollars in thousands) | ​ | 2021 | ​ | 2022 |  | 2023
Pfizer | ​ | $ | 10,160 | ​ | $ | 12,403 | ​ | $ | 12,522
Brazil | ​ | $ | 6,400 | ​ | $ | 9,452 | ​ | $ | 10,401
Chiesi | ​ | ​ | 189 | ​ | $ | 3,437 | ​ | $ | 17,495
Total revenues from selling goods | ​ | $ | 16,749 | ​ | $ | 25,292 | ​ | $ | 40,418
Revenues from license and R&D services | ​ | $ | 21,601 | ​ | $ | 22,346 | ​ | $ | 25,076

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration